SG11202101443WA - Methods of treating acute stress disorder and posttraumatic stress disorder - Google Patents
Methods of treating acute stress disorder and posttraumatic stress disorderInfo
- Publication number
- SG11202101443WA SG11202101443WA SG11202101443WA SG11202101443WA SG11202101443WA SG 11202101443W A SG11202101443W A SG 11202101443WA SG 11202101443W A SG11202101443W A SG 11202101443WA SG 11202101443W A SG11202101443W A SG 11202101443WA SG 11202101443W A SG11202101443W A SG 11202101443WA
- Authority
- SG
- Singapore
- Prior art keywords
- stress disorder
- methods
- treating acute
- posttraumatic
- acute stress
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862720063P | 2018-08-20 | 2018-08-20 | |
| PCT/IB2019/000940 WO2020039256A1 (en) | 2018-08-20 | 2019-08-20 | Methods of treating acute stress disorder and posttraumatic stress disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202101443WA true SG11202101443WA (en) | 2021-03-30 |
Family
ID=68542662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202101443WA SG11202101443WA (en) | 2018-08-20 | 2019-08-20 | Methods of treating acute stress disorder and posttraumatic stress disorder |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220117915A1 (en) |
| EP (1) | EP3840738A1 (en) |
| JP (1) | JP2021534192A (en) |
| CN (1) | CN113194935A (en) |
| AU (1) | AU2019323764A1 (en) |
| BR (1) | BR112021003107A2 (en) |
| CA (1) | CA3109258A1 (en) |
| IL (1) | IL280921A (en) |
| MX (1) | MX2021002012A (en) |
| SG (1) | SG11202101443WA (en) |
| TW (1) | TW202019400A (en) |
| WO (1) | WO2020039256A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2968992T3 (en) | 2013-03-15 | 2020-02-03 | Tonix Pharma Holdings Ltd | Eutetic formulations of cyclobenzaprine hydrochloride and mannitol |
| EP4255407A1 (en) * | 2020-12-07 | 2023-10-11 | Tonix Pharmaceuticals Holding Corp. | Cyclobenzaprine treatment for fibromyalgia |
| WO2023059728A1 (en) * | 2021-10-06 | 2023-04-13 | Tonix Pharmaceuticals Holding Corp. | Cyclobenzaprine for treatment or prevention of sexual dysfunction associated with mental health conditions in female patients |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1202722E (en) | 1999-08-13 | 2005-11-30 | L & L Technologies Llc | USES FOR THE TREATMENT OR PREVENTION OF SLEEP DISORDERS USING VERY LOW CYCLOBENZAPRINE DOSES |
| EP1202721A1 (en) | 1999-08-13 | 2002-05-08 | Vela Pharmaceuticals Inc. | Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof |
| PL2501234T3 (en) * | 2009-11-20 | 2018-01-31 | Tonix Pharma Holdings Ltd | Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine |
| CA2876902C (en) * | 2012-06-15 | 2021-07-13 | Tonix Pharmaceuticals, Inc. | Compositions and methods for transmucosal absorption |
| DK2968992T3 (en) * | 2013-03-15 | 2020-02-03 | Tonix Pharma Holdings Ltd | Eutetic formulations of cyclobenzaprine hydrochloride and mannitol |
| WO2016011451A1 (en) * | 2014-07-18 | 2016-01-21 | Medipath, Inc. | Compositions and methods for physiological delivery using cannabidiol |
-
2019
- 2019-08-20 MX MX2021002012A patent/MX2021002012A/en unknown
- 2019-08-20 AU AU2019323764A patent/AU2019323764A1/en active Pending
- 2019-08-20 WO PCT/IB2019/000940 patent/WO2020039256A1/en unknown
- 2019-08-20 BR BR112021003107-3A patent/BR112021003107A2/en unknown
- 2019-08-20 CN CN201980062283.3A patent/CN113194935A/en active Pending
- 2019-08-20 JP JP2021509201A patent/JP2021534192A/en active Pending
- 2019-08-20 US US17/269,106 patent/US20220117915A1/en active Pending
- 2019-08-20 CA CA3109258A patent/CA3109258A1/en active Pending
- 2019-08-20 TW TW108129709A patent/TW202019400A/en unknown
- 2019-08-20 EP EP19802247.7A patent/EP3840738A1/en active Pending
- 2019-08-20 SG SG11202101443WA patent/SG11202101443WA/en unknown
-
2021
- 2021-02-16 IL IL280921A patent/IL280921A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021534192A (en) | 2021-12-09 |
| IL280921A (en) | 2021-04-29 |
| US20220117915A1 (en) | 2022-04-21 |
| EP3840738A1 (en) | 2021-06-30 |
| MX2021002012A (en) | 2021-04-28 |
| BR112021003107A2 (en) | 2021-05-11 |
| TW202019400A (en) | 2020-06-01 |
| CN113194935A (en) | 2021-07-30 |
| WO2020039256A1 (en) | 2020-02-27 |
| AU2019323764A1 (en) | 2021-03-11 |
| CA3109258A1 (en) | 2020-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272627A (en) | Terpene-enriched cannabinoid composition and method of treatment | |
| HK1258448A1 (en) | Methods of diagnosing and treating conduct disorder | |
| GB2572746B (en) | Security elements and method of manufacture thereof | |
| SG11202101443WA (en) | Methods of treating acute stress disorder and posttraumatic stress disorder | |
| IL288091A (en) | Methods of characterizing and utilizing agent-condensate interactions | |
| IL266518A (en) | Methods of treating pah with combinations of ralinepag and other agents | |
| ZA202100106B (en) | Methods of treating and/or preventing actinic keratosis | |
| IL278759A (en) | Method of treating major depressive disorder | |
| GB201904357D0 (en) | Vacancy matching method and application | |
| IL283782A (en) | Anellosomes and methods of use | |
| SG11202101056RA (en) | HIGH-Mn STEEL AND METHOD OF PRODUCING SAME | |
| IL288353A (en) | Methods of treating cholangiocarcinoma | |
| IL276053A (en) | Therapeutic-gard and method of use thereof | |
| IL276905A (en) | Treatment and prevention of pre-eclampsia | |
| IL273155A (en) | Methods for treating depression and major depressive disorder | |
| PT3774241T (en) | Acetylated wood and method of making same | |
| PL3337462T3 (en) | Melatonin mini-tablets and method of manufacturing the same | |
| IL273500A (en) | Methods of treating acute or chronic pain | |
| IL264625A (en) | Method of preventing or treating hearing loss | |
| GB201805872D0 (en) | Method and assembly | |
| GB201810923D0 (en) | Compositions and method of treatment | |
| GB2543130B (en) | Improved coatings and method of applying the same | |
| GB2575017B (en) | Alignment Arrangement and Method of Alignment | |
| GB201815000D0 (en) | Treatment of hypothroidism and related conditions | |
| GB201812843D0 (en) | Impeller and method of manufacture |